Investornewsbreaks Kairos Pharma Ltd. (NYSE American: KAPA) Highlights Preclinical Data On GITR Agonist KROS 101 At AACR-JCA Conference
Kairos Pharma (NYSE American: KAPA) presented preclinical data on its GITR agonist, KROS 101, during the plenary session of the AACR-JCA conference.
Le Lézard2d
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keros Therapeutics, Inc. - KROS
Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. ("Keros" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...
EITB4d
Van der Poelek zazpigarrenez irabazi du munduko ziklo-kros txapelketa
Mathieu van der Poelek zazpigarrenez irabazi du munduko ziklo-kros txapelketa, eta historian sartu da, Eric De Vlaeminck belgikarraren errekorra berdinduta. Txirrindulari nederlandarrak erakustaldia e ...
6,242 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Bought by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC acquired a new stake in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and ...
EITB5d
Fem van Empel, munduko ziklo-kros txapelduna hirugarrenez
Fem van Empel, munduko ziklo-kros txapelduna hirugarrenez. Fem van Empel nederlandarrak irabazi du munduko ziklo-kros ...
Keros Therapeutics, Inc. Being Investigated on Behalf of Keros Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESS Newswire / January 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Keros ...
Post-Courier6d
Sir Julius Chan’s casket heads to Port Moresby
The program for the late New Ireland Governor Sir Julius Chan was running late, and when it became evident the helicopter was ...